Close

Prof David Schellenberg

Prof of Malaria & International Health

United Kingdom

Trained as a medical doctor in the UK, I’ve been working almost exclusively on malaria since 1995. I lived in Tanzania for 10 years and worked on a variety of descriptive epidemiology studies, clinical intervention trials and a pilot implementation programme. I was then based at LSHTM in London for 10 years, teaching and overseeing various malaria research and capacity strengthening activities, before spending 5 years at the Global Malaria Programme in WHO, Switzerland. There I supported the Malaria Vaccine Implementation Programme and the development of the first WHO recommendation for use of a malaria vaccine. I led the process to update existing and develop new malaria chemoprevention recommendations, now incorporated in the WHO malaria guidelines, and helped shape the development of new products for malaria prevention through the development of Preferred Product Characteristics for vaccines, chemoprevention and monoclonal antibodies.

My first degrees are in clinical science and medicine from the University of London, followed by a DTM&H from Liverpool, MRCP in London and PhD from the University of Barcelona, Spain. I was based at the Ifakara Health Institute, Tanzania, 1995-2001 and 2004-2007, and joined the School in 2003 to help build the IPTi Consortium. I was based in London 2007-2016, then WHO, Geneva 2016-2022 and returned to LSHTM in May 2022. Since May 2023 I have been working with BioNTech to support their portfolio of Global Health activities.

Affiliations

Department of Disease Control
Faculty of Infectious and Tropical Diseases

Centres

Centre for Evaluation
Malaria Centre
Centre for Maternal Adolescent Reproductive & Child Health
Vaccine Centre

Teaching

In 2022-2023 I reviewed our teaching on malaria and engaged with malaria distance learning and the ‘Malaria: from science to policy and practice’ intensive module. I supervise MSc students and teach on Applying Public Health principles, the DTM&H and Global Health Lecture Series.

Research

While at WHO (2016-2022) I was actively involved in the RTS,S Malaria Vaccine Implementation Programme having previously worked on phase 2 and 3 clinical development trials of RTS,S and SPf66. From 2014 to 2016 I led a programme to strengthen the use of data for malaria decision making in Africa. From 2009-2016 I Directed the ACT Consortium, answering key questions on malaria drug delivery, and was deputy director of the Malaria Capacity Development Consortium, working to strengthen capacity for health research in Africa. In addition to non-vector control approaches to malaria prevention I have worked on the evaluation of drug safety, the strengthening of health information systems, various methodological studies and micronutrient (iron and vitamin A) supplementation.

Research Area
Clinical trials
Epidemiology
Implementation science
Public health
Disease and Health Conditions
Malaria

Selected Publications

Meeting report: WHO consultation on malaria vaccine development, Geneva, 15-16 July 2019.
Vekemans, J; SCHELLENBERG, D; Benns, S; O'Brien, K; Alonso, P;
2021
Vaccine
Building momentum for malaria vaccine research and development: key considerations.
Chitnis, CE; SCHELLENBERG, D; Vekemans, J; Asturias, EJ; Bejon, P; Collins, KA; Crabb, BS; Herrera, S; Laufer, M; Rabinovich, NR; Roestenberg, M; Shearley, A; Tinto, H; Wentworth, M; O'Brien, K; Alonso, P;
2020
Malaria journal
Identifying research questions for HIV, tuberculosis, tuberculosis-HIV, malaria, and neglected tropical diseases through the World Health Organization guideline development process: a retrospective analysis, 2008-2018.
Hargreaves, S; Himmels, J; Nellums, LB; Biswas, G; Gabrielli, AF; Gebreselassie, N; Zignol, M; SCHELLENBERG, D; Norris, SL; Ford, N; Maher, D;
2020
Public health
Supporting capacity for research on malaria in Africa.
GREENWOOD, B; Gaye, O; Kamya, MR; Kibiki, G; Mwapasa, V; Phiri, KS; TAGBOR, H; Terlouw, D; Bates, I; Craig, A; Magnussen, P; Theander, TG; Bhasin, A; MCCULLOUGH, H; SCHELLENBERG, D;
2018
BMJ global health
The Impact of Introducing Malaria Rapid Diagnostic Tests on Fever Case Management: A Synthesis of Ten Studies from the ACT Consortium.
BRUXVOORT, KJ; LEURENT, B; CHANDLER, CI R; Ansah, EK; BAIDEN, F; Björkman, A; BURCHETT, HE D; CLARKE, SE; Cundill, B; DILIBERTO, DD; Elfving, K; GOODMAN, C; HANSEN, KS; Kachur, SP; LAL, S; Lalloo, DG; LESLIE, T; Magnussen, P; MANGHAM-JEFFERIES, L; Mårtensson, A; Mayan, I; Mbonye, AK; Msellem, MI; Onwujekwe, OE; OWUSU-AGYEI, S; ... HOPKINS, H.
2017
The American journal of tropical medicine and hygiene
Impact of introduction of rapid diagnostic tests for malaria on antibiotic prescribing: analysis of observational and randomised studies in public and private healthcare settings.
HOPKINS, H; BRUXVOORT, KJ; CAIRNS, ME; CHANDLER, CI R; LEURENT, B; Ansah, EK; BAIDEN, F; Baltzell, KA; Björkman, A; BURCHETT, HE D; CLARKE, SE; DILIBERTO, DD; Elfving, K; GOODMAN, C; HANSEN, KS; Kachur, SP; LAL, S; Lalloo, DG; Leslie, T; Magnussen, P; Jefferies, LM; Mårtensson, A; Mayan, I; Mbonye, AK; Msellem, MI; ... WHITTY, CJ M.
2017
BMJ (Clinical research ed)
Malaria in Middle Childhood and Adolescence
BROOKER, SJ; CLARKE, S; Fernando, D; Gitonga, CW; Nankabirwa, J; SCHELLENBERG, D; GREENWOOD, B;
2017
Disease Control Priorities, Third Edition (Volume 8): Child and Adolescent Health and Development
Cluster randomized trial of text message reminders to retail staff in tanzanian drug shops dispensing artemether-lumefantrine: effect on dispenser knowledge and patient adherence.
BRUXVOORT, K; Festo, C; Kalolella, A; CAIRNS, M; Lyaruu, P; Kenani, M; Kachur, SP; GOODMAN, C; SCHELLENBERG, D;
2014
The American journal of tropical medicine and hygiene
See more information